Evaluation of Panbio rapid antigen test for SARS‐CoV‐2 in symptomatic patients and their contacts: a multicenter study

Background: Point-of-care rapid tests to identify SARS-CoV-2 can have clinical benefits. Methods: A cross-sectional study in adults visiting emergency services or screening sites of referral hospitals for COVID-19 to validate the diagnostic performance of a rapid antigen test for SARS-CoV-2 (Abbott&...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ireri Thirion-Romero, Dr. Selene Guerrero-Zúñiga, Dr. Alexandra Arias-Mendoza, Dr. Dora Patricia Cornejo-Juárez, Dr. Patricia Meza-Meneses, Dr. Darwin Stalin Torres-Erazo, Dr. Thierry Hernández-Gilsoul, Dr. Arturo Galindo-Fraga, Dr. Isabel Villegas-Mota, Dr. Jesús Sepúlveda-Delgado, Dr. Santiago Ávila-Ríos, Dr. Eduardo Becerril-Vargas, Rosario Fernández-Plata, TIT Midori Pérez-Kawabe, Dr. Ana Coeto-Cano, Dr. Joel Armando Vázquez-Pérez, Dr. Simón Kawa-Karasik, Dr. Gustavo Reyes-Terán, Dr. José Rogelio Pérez-Padilla
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	COVID-19 SARS-CoV-2 point of care test rapid antigen test Panbio Abbott Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/36c9ec7fdecf47a98ba2299bde37eda2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Evaluation of Panbio rapid antigen test for SARS‐CoV‐2 in symptomatic patients and their contacts: a multicenter study

Ejemplares similares